市场调查报告书
商品编码
1572465
基于人工智慧的手术机器人市场、机会、成长动力、产业趋势分析与预测,2024-2032AI-based Surgical Robots Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
2023 年,全球基于人工智慧的手术机器人市场估值为57 亿美元。 预测显示出强劲的成长轨迹,预计2024 年至2032 年复合年增长率为16.2%。技术进步、外科手术的增加程序、支持性政府措施和资金等因素。
微创手术以创伤小、恢復速度快而闻名,越来越多地采用基于人工智慧的手术机器人。这些机器人提供增强的控制和精确度,这对于此类手术至关重要。例如,Meritas Health 报告称,美国每年进行超过 1500 万例腹腔镜手术。此外,基于人工智慧的手术机器人提高了精确度,降低了人为错误风险。这会带来更好的患者治疗效果、降低併发症发生率并缩短住院时间。
将人工智慧融入机器人手术正在彻底改变手术实践,提高其效率、安全性和有效性。人工智慧整合有助于精细的操作,最大限度地减少组织损伤,缩短恢復时间并提高患者的治疗效果。透过简化操作,人工智慧不仅可以缩短手术时间,还可以在同一时间内进行更多的手术。这种效率在高要求的手术环境中至关重要,可以提高营运吞吐量并控制医疗成本。此外,人工智慧驱动的预测分析和模拟工具支援术前规划。这些工具使外科医生能够可视化不同的场景和结果,为复杂的手术做好准备,减少术中意外并提高手术效果。
基于人工智慧的手术机器人产业根据类型、应用、最终用途和地区进行分类。
2023 年,硬体部门的收入份额领先,价值 35 亿美元。先进的成像系统,包括 3D 成像、术中成像和即时视觉化工具,对于指导基于人工智慧的手术过程至关重要。随着对这些高效能成像系统的需求激增,医疗保健提供者越来越多地采用尖端的硬体技术。其中包括先进的机械手臂、精密仪器和人工智慧整合成像系统,所有这些都旨在提高护理品质。
2023年,医院占据73.9%的主导市场。神经外科、心血管外科和肿瘤科等医院的专业外科服务发现基于人工智慧的手术机器人具有巨大价值。这些机器人在执行需要精确和即时决策的复杂手术中发挥着重要作用。此外,随着医院寻求可扩展和适应性强的手术解决方案,基于人工智慧的手术机器人的模组化和可自订特性成为一个重要的吸引力,特别是对于那些旨在扩大其手术能力的医院来说。
北美基于人工智慧的手术机器人市场在 2023 年的收入为 38 亿美元。 预测显示 2024 年至 2032 年复合年增长率为 14.9%。为了满足这种不断增长的需求,基于人工智慧的手术机器人正在占据重要地位,特别是在大容量手术中心。此外,北美的监管环境有利于人工智慧手术技术的采用。美国监管机构,特别是 FDA,为包括人工智慧手术机器人在内的医疗设备提供简化的批准途径,并加速其市场进入。
The Global AI-based Surgical Robots Market was valued at USD 5.7 billion in 2023. Projections indicate a robust growth trajectory, with an anticipated CAGR of 16.2% from 2024 to 2032. This surge can be largely attributed to technological advancements, an uptick in surgical procedures, and supportive government initiatives and funding, among other factors.
Minimally invasive procedures, known for being less traumatic and promoting quicker recovery, are increasingly adopting AI-based surgical robots. These robots provide enhanced control and precision, crucial for such surgeries. For instance, Meritas Health reports that the U.S. sees over 15 million laparoscopic surgeries annually. Moreover, AI-based surgical robots enhance precision, mitigating human error risks. This leads to superior patient outcomes, reduced complication rates, and shorter hospital stays.
The infusion of AI into robotic surgeries is revolutionizing surgical practices, enhancing their efficiency, safety, and effectiveness. AI integration facilitates delicate maneuvers, minimizing tissue damage, shortening recovery times, and boosting patient outcomes. By streamlining operations, AI not only cuts down surgery durations but also allows for a greater number of procedures in the same timeframe. This efficiency is vital in high-demand surgical environments, enhancing operational throughput and curbing healthcare costs. Furthermore, AI-driven predictive analytics and simulation tools bolster preoperative planning. By enabling surgeons to visualize diverse scenarios and outcomes, these tools prepare them for intricate surgeries, reducing intraoperative surprises and elevating surgical results.
The AI-based surgical robots industry is classified based on type, application, end-use, and region.
In 2023, the hardware segment led the revenue share, valued at USD 3.5 billion. Advanced imaging systems, including 3D imaging, intraoperative imaging, and real-time visualization tools, are pivotal for guiding AI-based surgical procedures. As the demand for these high-performance imaging systems surges, healthcare providers are increasingly adopting cutting-edge hardware technologies. This encompasses advanced robotic arms, precision instruments, and AI-integrated imaging systems, all aimed at elevating care quality.
In 2023, hospitals commanded a dominant market share of 73.9%. Specialized surgical services in hospitals, such as neurosurgery, cardiovascular surgery, and oncology, find immense value in AI-based surgical robots. These robots are instrumental in executing intricate surgeries that demand precision and real-time decision-making. Furthermore, as hospitals seek scalable and adaptable surgical solutions, the modular and customizable nature of AI-based surgical robots becomes a significant draw, especially for those aiming to broaden their surgical capabilities.
North America AI-based surgical robots market held a revenue of USD 3.8 billion in 2023. Projections suggest a CAGR of 14.9% from 2024 to 2032. The region witnesses a consistent rise in surgical procedures, fueled by an aging demographic, increased elective surgeries, and evolving surgical techniques. To cater to this surging demand, AI-based surgical robots are finding a prominent place, especially in high-volume surgical centers. Additionally, the regulatory landscape in North America favors the adoption of AI surgical technologies. U.S. regulatory bodies, notably the FDA, offer streamlined approval pathways for medical devices, including AI-powered surgical robots, expediting their market entry.